跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,142 条关于
“BCR-ABL1 gene”
全部
13,142
临床试验
5,694
药物
2,256
机构
81
资讯
5,111
5年前
FDA Approves Scemblix (asciminib) for Chronic Myeloid Leukemia with Novel Mechanism
4年前
Scemblix Receives European Commission Approval for CML Treatment After TKI Failure
4年前
FDA Approves Novartis' Scemblix for Resistant Philadelphia Chromosome-Positive CML
4年前
Scemblix Receives Positive CHMP Opinion for CML Treatment After TKI Failure
去年
Fangzhou Expands Access to Breakthrough Leukemia Treatment with Ponatinib Launch in China
去年
Scemblix Demonstrates Superior Efficacy Over TKIs in First-Line CML Treatment: 96-Week ASC4FIRST Trial Results
去年
FDA Approves Danziten (Nilotinib) as First Meal- unrestricted Option for CML Patients
去年
SOHO 2024: Advancements in ALL, CML, and CLL Treatment Strategies
9个月前
Ascentage Pharma's Olverembatinib Shows 23.1% Response Rate in Rare GIST Subtype with Novel Lipid Metabolism Mechanism
去年
Ascentage Pharma Raises $192M in Oversubscribed Share Placement to Advance Cancer Pipeline
第 1 页,共 512 页
上一页
下一页